ARTICLE | Clinical News
Inhaled Bimosiamose: Phase II data
March 14, 2011 7:00 AM UTC
Top-line data from a double-blind, crossover, German Phase II trial in 77 patients with moderate to severe COPD showed that twice-daily inhaled Bimosiamose met the primary endpoint of significantly re...